6-Hydroxymethyl-nicotinic acid ethyl ester, 95.0%, 10g

2-(2-((3-Fluorobenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

tert-Butyl 3-bromoazetidine-1-carboxylate, 95.0%, 1g

4-Oxo-1-propyl-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxylic acid, 97%, 250mg

In powder +2% MgO 99.999% 200 micron 50 g

Benzyl Glycinate Hydrochloride>98.0%(HPLC)(T)25g

CYCLOPENTANECARBOXYLIC ACID, 2-OXO-, 1-METHYLETHYL ESTER, 95%, 1g

4,4',4'',4'''-(Ethene-1,1,2,2-tetrayl)tetrabenzaldehyde, 97.0%, 1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methoxy-5-oxopentanoic acid, 97.0%, 500g

4-Phenoxybenzenesulfonamide, 97.0%, 1g

4-BROMO-6-INDAZOLECARBOXYLIC ACID METHYL ESTER, 95%, 25g

1-Boc-4-(4-Iodo-1H-pyrazol-1-yl)piperidine, 95.0%, 1g

(S)-tert-butyl 4-benzyl-2-isopropylpiperazine-1-carboxylate, 95%, 1g